Skip to content
lifestyle.sli.mg
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Editas Medicine, Inc.
Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
October 14, 2026
Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia
October 8, 2026
Editas Medicine Reports Inducement Grants to New Chief Medical Officer
September 9, 2026
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
September 8, 2026
Editas Medicine to Participate in Upcoming Investor Conferences
September 1, 2026
Editas Medicine Announces Second Quarter 2026 Results and Business Updates
August 5, 2026
Editas Medicine Strengthens Board of Directors with Appointment of Patrick T. Ellinor, M.D., Ph.D.
August 4, 2026
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
May 28, 2026
Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering
May 26, 2026
Editas Medicine Announces Proposed Public Offering
May 26, 2026
1
2
Next Page
→